Adverse outcomes with extracorporeal adsorbent blood treatments in toxic systemic inflammation: a perspective on possible mechanisms

BACKGROUND: Extracorporeal blood purification (EBP) treatments may be used in patients with sepsis and related conditions to mitigate toxic systemic inflammation, prevent or reverse vital organ injury, and improve outcome. These treatments lack demonstrable efficacy, but are generally considered saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Matson, James, Lange, Paul, Honore, Patrick M., Chung, Kevin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652582/
https://www.ncbi.nlm.nih.gov/pubmed/36370238
http://dx.doi.org/10.1186/s13613-022-01078-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652582/
https://www.ncbi.nlm.nih.gov/pubmed/36370238
http://dx.doi.org/10.1186/s13613-022-01078-6

Ejemplares similares